Articles tagged with Viral Infections
Researchers are investigating antioxidants for preventing or treating rickettsia bacteria, a deadly tick-borne illness. The study, funded by the National Institute of Allergy and Infectious Disease, aims to identify novel therapeutic targets for rickettsial diseases.
Scientists identified a genetic element that the dengue virus uses to replicate, triggering the potentially fatal illness known as dengue hemorrhagic fever. The discovery provides a model for RNA replication in flaviviruses, which cause millions of cases of human illness each year.
A study found that HPV16 and 18 variants persist longer in people whose ancestors are from the same geographical area as the virus. The research suggests that genetic variants specific to racial groups may play a role in persistence. Future studies should examine possible mechanisms behind variant-specific immune evasion.
Researchers at Harvard Medical School have created a new mouse model that allows scientists to study how the immune system responds to Chlamydia. The breakthrough enables tracking of T cell responses in reproductive tissues, shedding light on potential avenues for developing vaccines against this common STD.
Researchers have identified a possible mechanism used by an important motor protein that enables bacteria to travel through the bloodstream and infect organs such as the heart. The discovery may lead to the development of new pharmacological therapies that can target and kill bacteria, preventing or minimizing damage to the heart muscle.
Researchers have discovered a potent inhibitor of HPV infection in the compound carrageenan, found in sexual lubricants and baby food. The study suggests that carrageenan could be effective in preventing HPV-related genital disease, complementing existing vaccines and treatments.
Two medical researchers, Chen Ding-Shinn and Rao Zihe, have made significant contributions to understanding infectious diseases and developing a comprehensive vaccination campaign. Mathematicians Jacob Palis and C.S. Seshadri are recognized for their groundbreaking work in dynamic systems and algebraic geometry, respectively.
Researchers at MSU have developed a new cell line that can grow nearly all types of flu viruses, potentially leading to faster and cheaper vaccine production. This could help address the issues with traditional influenza vaccine production methods, including long production times and limited supply.
A biomarker named procalcitonin can reduce the length of antibiotic treatment for community-acquired pneumonia (CAP) patients. Studies found that lower procalcitonin levels could shorten antibiotic use by an average of seven days, but guidelines suggest shorter courses and caution against over-reliance on this marker.
A new study by veterinary researchers at Oregon State University has linked vesivirus to a major epidemic of abortion in Kentucky Thoroughbred mares. The findings suggest that broodmares are being commonly exposed to vesivirus from unknown sources, and that exposure to such horses might be a concern for pregnant women.
A study by Ohio State University researchers found that mice lacking a specific gene produce fewer parasites in their livers, preventing the disease from developing. This discovery may lead to the creation of new drugs to treat different diseases affecting the liver.
A new H5N1 vaccine has demonstrated cross-protection in ferrets against different variants of the virus, offering a promising solution for stockpiling in the event of a human outbreak. The vaccine was shown to completely protect ferrets from infection and reduce viral multiplication.
Researchers found SIVcpz infection in up to 35% of chimpanzees in West Africa, allowing for genetic comparisons between HIV-1 and its simian counterpart. The study provides insights into the origins of HIV-1 and how it made the jump from animals to humans.
Infected pet rodents can transmit lymphocytic choriomeningitis virus (LCMV) to humans through organ transplants. The virus, a member of the Arenaviridae family, has been linked to severe disease in immuno-suppressed patients.
The hepatitis C virus uses its protease activity to destroy a key antiviral signaling protein called MAVS, preventing infected cells from producing type 1 interferon. This allows the virus to evade the immune system and persist indefinitely, highlighting potential new treatment strategies.
Researchers identified 37 HIV-1 protein fragments that triggered an immune response in cytotoxic T lymphocytes. Healthy donors responded with large quantities of interferon gamma, while infected patients showed only a small proportion of cells mounting an adequate response.
A new study offers a simpler approach to diagnosing urinary incontinence in women by asking patients three simple questions. Meanwhile, an update to the US hepatitis C profile reveals that infected individuals are entering their 40s and 50s, increasing the risk of disease consequences such as cirrhosis and liver cancer.
A $4.5 million partnership aims to improve lung health by studying immune responses to infections and allergens in Canadians affected by asthma, cystic fibrosis, and other respiratory diseases. Experts available for comment on the initiative and its implications.
Researchers identify key factors that contribute to the amplification and transmission of West Nile Virus, including drought-induced conditions and specific mosquito species. By understanding these local conditions, control strategies can be devised to prevent the spread of the disease.
Researchers found that T cells responding to Epstein-Barr virus-encoded nuclear antigen1 (EBNA1) are hyper-reactive and produce interferon-gamma, which shapes immune responses. This hyper-reactivity may trigger the destruction of myelin sheathing in nerve cells, leading to MS.
Researchers used mathematical modeling to simulate worldwide outbreaks and concluded that restrictions on air travel would achieve very little in controlling the spread of a new flu virus. Local measures such as vaccines and antiviral drugs could be more effective in controlling the spread of the virus.
Researchers discovered erythrovirus genome persistence in human tissues, which is ubiquitous and life-long. The Bioportfolio provides a novel database for analyzing microbial species and their variants, offering potential long-term permanence for gene therapy vectors.
Researchers have developed a vaccine that prevents haemorrhagic fever developing in monkeys infected with the deadly Marburg virus. The vaccine was found to be highly effective as a post-exposure treatment, with all treated monkeys surviving for at least 80 days.
A post-exposure vaccine has been shown to protect monkeys against the deadly Marburg virus. Researchers tested the vaccine in a study involving non-human primates and found it to be highly effective in preventing severe symptoms of the disease.
A new experimental vaccine has been shown to protect nonhuman primates against Marburg virus infection, even when administered after exposure. The study found that all treated monkeys survived for at least 80 days, while controls succumbed to the disease within 12 days.
A viral protein called p12 activates infected T cells and causes them to become sticky, adhering to other T cells. This enhanced adherence is due to clustering of special proteins on the surface of T cells.
Scientists have developed a new method using molecular beacons to visualize and detect the genome of the respiratory virus in live cells. This technique allows for early detection of the virus, which is essential for treating the disease.
A team of scientists has discovered a new hantavirus in an African wood mouse, which is related to viruses causing severe disease in humans in Central and Eastern Europe. The virus was found to have similarities with other hantaviruses, including the Dobrava virus, and can infect humans, according to preliminary evidence.
A study found that Japanese encephalitis is prevalent in Bali, particularly among children under 10 years old. The annual incidence rate for this age group was 8.2 per 100,000, resulting in nine deaths and 31 cases of serious neurological disability.
A large-scale model simulates the spread of a pandemic influenza virus in the US population, exploring the impact of interventions such as vaccination and social distancing. The study finds that stockpiling vaccines and implementing a combination of mitigation strategies could be effective in slowing the spread of the flu.
Adult stem cells can make new tendon tissue and repair damaged tendons in rats. The study demonstrates potential for using this technology to treat musculoskeletal injuries and degenerative diseases.
Researchers at Ohio State University have discovered that a cancer virus protein is necessary for the virus to successfully infect and reproduce in the body. The protein, p13, plays a critical role in the early phase of infection, and its function could be targeted by new drugs or vaccines.
The HPV vaccine has the potential to prevent cervical cancer, but understanding its context is vital. Vaccination should not be misconstrued as a green light for permissive behavior, but rather as a means of preventing infection in young women.
Scientists detect novel gammaretrovirus more frequently in men with RNASEL gene mutations, sparking questions about a potential viral cause for prostate cancer. The discovery raises several questions for future experimentation, including the relationship between the virus and the disease.
Researchers found that horse antibodies to H5N1 protected dog kidney cells and mice infected with the deadly virus from death. Low doses of antibody (50µg) protected 70% of mice, while higher doses (100µg) offered full protection.
A study found that Vesivirus antibodies were present in over 40% of patients with clinical hepatitis, suggesting a potential link between the virus and human disease. The research also highlights the widespread distribution of Vesivirus in various animal species, including fish and primates.
A recent study from Thailand found a significant association between bocavirus (HBoV) and lower respiratory tract infections (LRTI) in young children. HBoV was detected in over half of hospitalized patients under one year old, highlighting the need for further research to understand the virus's role in human disease.
The study found that small mutations can change the binding site preference of the avian virus from bird to human receptors, increasing its chances of infection. This critical step is a key reason why most avian influenza viruses are not easily transmitted between humans.
Researchers found that carnivore parvoviruses and the human B19 erythrovirus undergo rapid evolution when switching host species. This contradicts the assumption that DNA viruses exhibit slower mutation rates compared to their hosts and other DNA viruses.
Researchers have created genetically modified mosquitoes resistant to the Type 2 dengue fever virus, which infects 50 million people annually. The mosquitoes showed high levels of resistance and were able to reproduce, making them a promising tool for controlling mosquito-borne diseases.
Researchers propose using chemotherapy to treat avian flu, citing success in treating a related immune disorder called haemophagocytic lymphohistiocytosis. The treatment involves etoposide and corticosteroids, and has shown promise in reducing mortality rates in similar cases.
Researchers tracked individuals infected with EBV, RRV, or Q fever and found post-infective fatigue syndrome lasting six months or longer. The study suggests that brain damage during acute infection phase may be responsible for chronic fatigue symptoms.
Researchers found that Culex mosquitoes changed their feeding behavior from American robins to humans in the fall, leading to large-scale outbreaks of disease. The study's findings suggest a continent-wide phenomenon and may explain why West Nile virus outbreaks are more intense in the US than in Europe and Africa.
Researchers have discovered consistent genetic differences in the southern house mosquito, explaining the geographical distribution of disease-transmitting strains. The study found that different strains of the mosquito are responsible for serious diseases like elephantiasis and West Nile virus.
Researchers detected a novel virus, XMRV, in human prostate tumors with two copies of the RNASEL gene mutation. The study validates the use of DNA-hunting 'virus chip' technology to discover previously unknown viruses and potentially uncover new viral causes for disease.
Researchers at EMBL and IVMS have obtained a detailed structural picture of the ZEBRA protein, which plays a key role in activating the EBV. The study reveals a potential weak point that could be targeted by antiviral drugs to block the virus's activation.
A study by Gibson and Mace found that villages with improved water supply in rural Ethiopia experienced a significant increase in birth rates, contradicting the expected reduction in fertility. The researchers suggest that development programs should be more comprehensive, incorporating access to contraceptives.
Respiratory syncytial virus (RSV) infections in infants and young children may be shortened by three weeks per degree Celsius rise in annual mean daily temperature. Rising temperatures may also increase the spread of other respiratory illnesses, such as influenza.
A team of biologists developed improved software to analyze virus structures, revealing new details about the Epsilon 15 virus that infects salmonella. The advancements enable scientists to observe previously invisible features, including non-symmetric components and a core with unknown function.
Researchers at UW-Madison have discovered a systematic mechanism for the influenza virus to package its genetic materials, enabling the development of new antiviral drugs and more efficient vaccine production. This finding has significant implications for addressing avian influenza pandemics.
Researchers have developed a 'nanoshuttle' that uses viral particles to precisely home to disease, where it can perform various functions such as destroying tissue or emitting signals. The system has the potential to deliver stem cells to damaged areas, potentially treating heart disease and cancer.
Researchers have identified a new vitamin D-related compound that inhibits the production of c-Fos protein, which plays a key role in bone breakdown and resorption. In contrast, a nuclear protein called Tlx acts as an oxygen-sensing switch to regulate angiogenesis in retinal astrocytes.
The National Institutes of Health is testing avian influenza vaccines to prevent a possible pandemic. Saint Louis University School of Medicine is conducting a research study using a killed flu virus vaccine in children ages 2-9.
A study on H5N1 influenza virus infection in cats reveals systemic disease with widespread viral spread to various organ systems, including respiratory and digestive tracts. This finding has significant implications for understanding the mechanisms of avian influenza transmission to humans.
Researchers found that group B coxsackieviruses infect cells through an indirect route, utilizing signaling pathways and exploiting more accessible receptors. This understanding may lead to future therapies to block viral infections and contribute to clinical benefits.
Researchers used novel antisense drugs to interrupt normal Ebola virus replication, showing protection in non-human primates. The therapy directly targets the virus and may be more potent than current anti-viral treatments.
A Yale study reveals how toll-like receptors recognize viral infections without self-DNA recognition, highlighting potential for treating autoimmune disorders like SLE. The research also shows that TLR localization is crucial in maintaining the balance between viral and self nucleic acid recognition.
Researchers found that a hepatitis C virus protein accelerates the breakdown of a critical tumor suppressor, leading to liver cell proliferation and increasing cancer risk. This discovery could lead to improved treatment strategies for patients with chronic hepatitis C.
Researchers found that chest x-rays were a reliable predictor of mortality in patients with avian flu, with the severity of findings linked to patient outcomes. Five patients who survived still had abnormal lung appearances on CT scans after discharge.
Research reveals that patients with Hepatitis C are using more healthcare resources, including increased hospitalizations, physician visits, and costs due to disease progression. The study highlights the urgent need for better HCV treatment decisions as the patient population ages.